» Articles » PMID: 1378258

Mononuclear Cell Subsets and Coronary Artery Lesions in Kawasaki Disease

Overview
Journal Arch Dis Child
Specialty Pediatrics
Date 1992 Jun 1
PMID 1378258
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

The peripheral blood mononuclear cell subsets in patients with Kawasaki disease and coronary artery lesions were investigated. Of the 106 patients 14 had lesions. Patients with Kawasaki disease and coronary artery lesions were found to have increased counts of CD14+ macrophages/monocytes compared with those of patients with Kawasaki disease without lesions. The absolute counts of CD14+ macrophages/monocytes form an important parameter to determine the severity of vascular damage during acute Kawasaki disease.

Citing Articles

Establishment and validation of a nomogram for predicting intravenous immunoglobulin resistance and coronary artery lesion involvement in Kawasaki disease: a retrospective study.

Gao Y, Peng L, Liu J, Zhao C Clin Rheumatol. 2025; 44(2):799-809.

PMID: 39808233 DOI: 10.1007/s10067-025-07321-2.


The mechanism underlying B-cell developmental dysfunction in Kawasaki disease based on single-cell transcriptomic sequencing.

Lin Q, Wang Z, Ding G, Li G, Chen L, Qiu Q Front Immunol. 2024; 15:1438640.

PMID: 39507528 PMC: 11537935. DOI: 10.3389/fimmu.2024.1438640.


Expansion of a Novel Subset of L-Selectin Classical Monocytes in Kawasaki Disease.

Jin Y, Geng Z, Lin K, Gu X, Feng X, Fu S J Inflamm Res. 2024; 17:6193-6201.

PMID: 39281780 PMC: 11397173. DOI: 10.2147/JIR.S468472.


Long-term cardiovascular inflammation and fibrosis in a murine model of vasculitis induced by cell wall extract.

Lombardi Pereira A, Aubuchon E, Moreira D, Lane M, Carvalho T, Mesquita T Front Immunol. 2024; 15:1411979.

PMID: 38989288 PMC: 11234797. DOI: 10.3389/fimmu.2024.1411979.


Bioinformatic analysis of underlying mechanisms of Kawasaki disease via Weighted Gene Correlation Network Analysis (WGCNA) and the Least Absolute Shrinkage and Selection Operator method (LASSO) regression model.

Xie Y, Shi H, Han B BMC Pediatr. 2023; 23(1):90.

PMID: 36829193 PMC: 9951419. DOI: 10.1186/s12887-023-03896-4.


References
1.
Furukawa S, Matsubara T, Motohashi T, Nakachi S, Sasai K, YABUTA K . Expression of Fc epsilon R2/CD23 on peripheral blood macrophages/monocytes in Kawasaki disease. Clin Immunol Immunopathol. 1990; 56(2):280-6. DOI: 10.1016/0090-1229(90)90149-k. View

2.
Matsubara T, Furukawa S, YABUTA K . Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions. Clin Immunol Immunopathol. 1990; 56(1):29-36. DOI: 10.1016/0090-1229(90)90166-n. View

3.
Leung D, COTRAN R, Kurt-Jones E, Burns J, Newburger J, Pober J . Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease. Lancet. 1989; 2(8675):1298-302. DOI: 10.1016/s0140-6736(89)91910-7. View

4.
Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T . High-dose intravenous gammaglobulin for Kawasaki disease. Lancet. 1984; 2(8411):1055-8. DOI: 10.1016/s0140-6736(84)91504-6. View

5.
Furukawa S, Matsubara T, Tsuji K, Motohashi T, Okumura K, YABUTA K . Serum soluble CD4 and CD8 levels in Kawasaki disease. Clin Exp Immunol. 1991; 86(1):134-9. PMC: 1554161. DOI: 10.1111/j.1365-2249.1991.tb05785.x. View